These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 22786790

  • 1. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
    Beuck S, Sigmund G, Koch A, Schänzer W, Pokrywka A, Kwiatkowska D, Thevis M.
    Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
    [Abstract] [Full Text] [Related]

  • 2. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G, Koch A, Orlovius AK, Guddat S, Thomas A, Schänzer W, Thevis M.
    Drug Test Anal; 2014 Sep; 6(11-12):1197-205. PubMed ID: 24913825
    [Abstract] [Full Text] [Related]

  • 3. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M, Milosovich S, Licea-Perez H, Knecht D, Cavalier T, Schänzer W.
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [Abstract] [Full Text] [Related]

  • 4. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G, Carius Garrido B, Dias Leal F, Costa Padilha M, Mazzarino M, de la Torre X, Botre F, Radler de Aquino Neto F.
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [Abstract] [Full Text] [Related]

  • 5. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
    Guddat S, Solymos E, Orlovius A, Thomas A, Sigmund G, Geyer H, Thevis M, Schänzer W.
    Drug Test Anal; 2011 Nov; 3(11-12):836-50. PubMed ID: 22135086
    [Abstract] [Full Text] [Related]

  • 6. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S, Bornatsch W, Lagojda A, Schänzer W, Thevis M.
    Drug Test Anal; 2011 Nov; 3(11-12):756-70. PubMed ID: 22213684
    [Abstract] [Full Text] [Related]

  • 7. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W, Guddat S, Thomas A, Opfermann G, Geyer H, Thevis M.
    Drug Test Anal; 2013 Nov; 5(11-12):810-8. PubMed ID: 23873860
    [Abstract] [Full Text] [Related]

  • 8. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.
    Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schänzer W, Thevis M.
    Anal Bioanal Chem; 2011 Aug; 401(2):493-505. PubMed ID: 21455647
    [Abstract] [Full Text] [Related]

  • 9. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
    Görgens C, Guddat S, Orlovius AK, Sigmund G, Thomas A, Thevis M, Schänzer W.
    Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
    [Abstract] [Full Text] [Related]

  • 10. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W.
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [Abstract] [Full Text] [Related]

  • 11. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
    Mazzarino M, de la Torre X, Fiacco I, Pompei C, Calabrese F, Botrè F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul 15; 931():75-83. PubMed ID: 23777613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.
    Thevis M, Sigmund G, Thomas A, Gougoulidis V, Rodchenkov G, Schänzer W.
    Eur J Mass Spectrom (Chichester); 2009 Jul 15; 15(4):507-15. PubMed ID: 19661559
    [Abstract] [Full Text] [Related]

  • 17. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F, Mazzucco E, Gennaro MC, Marengo E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May 15; 927():22-36. PubMed ID: 23317577
    [Abstract] [Full Text] [Related]

  • 18. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
    Thevis M, Guddat S, Schänzer W.
    Steroids; 2009 Mar 15; 74(3):315-21. PubMed ID: 19007801
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing.
    Thevis M, Krug O, Schänzer W.
    Rapid Commun Mass Spectrom; 2013 May 15; 27(9):993-1004. PubMed ID: 23592202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.